ClinicalTrials.govpublic full text
Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density
osteoporosis, 2-methylene-19-nor-(20s)-1a, 25-dihydroxyvitamin d3, vitamin d, bone density conservation agents, bone regeneration, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 888102
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.